178 related articles for article (PubMed ID: 28793269)
1. Cell-Type-Specific Gene Programs of the Normal Human Nephron Define Kidney Cancer Subtypes.
Lindgren D; Eriksson P; Krawczyk K; Nilsson H; Hansson J; Veerla S; Sjölund J; Höglund M; Johansson ME; Axelson H
Cell Rep; 2017 Aug; 20(6):1476-1489. PubMed ID: 28793269
[TBL] [Abstract][Full Text] [Related]
2. FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
Tong K; Hu Z
Virchows Arch; 2021 Apr; 478(4):647-658. PubMed ID: 32812119
[TBL] [Abstract][Full Text] [Related]
3. DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
Malouf GG; Su X; Zhang J; Creighton CJ; Ho TH; Lu Y; Raynal NJ; Karam JA; Tamboli P; Allanick F; Mouawad R; Spano JP; Khayat D; Wood CG; Jelinek J; Tannir NM
Clin Cancer Res; 2016 Dec; 22(24):6236-6246. PubMed ID: 27256309
[TBL] [Abstract][Full Text] [Related]
4. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
Skala SL; Wang X; Zhang Y; Mannan R; Wang L; Narayanan SP; Vats P; Su F; Chen J; Cao X; Siddiqui J; Argani P; Cieślik MP; Giordano TJ; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Eur Urol; 2020 Jul; 78(1):63-74. PubMed ID: 32299640
[TBL] [Abstract][Full Text] [Related]
5. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
[TBL] [Abstract][Full Text] [Related]
6. Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles.
Furge KA; Lucas KA; Takahashi M; Sugimura J; Kort EJ; Kanayama HO; Kagawa S; Hoekstra P; Curry J; Yang XJ; Teh BT
Cancer Res; 2004 Jun; 64(12):4117-21. PubMed ID: 15205321
[TBL] [Abstract][Full Text] [Related]
7. Mechanism and function of decreased FOXO1 in renal cell carcinoma.
Zhou L; Yin B; Liu Y; Hong Y; Zhang C; Fan J
J Surg Oncol; 2012 Jun; 105(8):841-7. PubMed ID: 22213032
[TBL] [Abstract][Full Text] [Related]
8. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression profiling of Xp11 renal cell carcinoma.
Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
[TBL] [Abstract][Full Text] [Related]
10. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
[TBL] [Abstract][Full Text] [Related]
11. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
[TBL] [Abstract][Full Text] [Related]
12. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
13. Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron.
Büttner F; Winter S; Rausch S; Reustle A; Kruck S; Junker K; Stenzl A; Agaimy A; Hartmann A; Bedke J; Schwab M; Schaeffeler E
Eur Urol; 2015 Dec; 68(6):1016-20. PubMed ID: 26072688
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.
Young AN; Amin MB; Moreno CS; Lim SD; Cohen C; Petros JA; Marshall FF; Neish AS
Am J Pathol; 2001 May; 158(5):1639-51. PubMed ID: 11337362
[TBL] [Abstract][Full Text] [Related]
16. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
17. Novel molecular signatures and potential therapeutics in renal cell carcinomas: Insights from a comparative analysis of subtypes.
Caliskan A; Andac AC; Arga KY
Genomics; 2020 Sep; 112(5):3166-3178. PubMed ID: 32512143
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
[TBL] [Abstract][Full Text] [Related]
19. Network-based metabolic characterization of renal cell carcinoma.
Pandey N; Lanke V; Vinod PK
Sci Rep; 2020 Apr; 10(1):5955. PubMed ID: 32249812
[TBL] [Abstract][Full Text] [Related]
20. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
